Literature DB >> 12112483

Predicting major depression in brain tumor patients.

David K Wellisch1, Thomas A Kaleita, Donald Freeman, Timothy Cloughesy, Jeffrey Goldman.   

Abstract

Very few studies have been performed utilizing DSM criteria to diagnose major depressive disorder (MDD) in adult brain tumor patients. This study aimed to diagnose MDD in this population using DSM-IV criteria.Eighty-nine adult brain tumor patients were examined in an ambulatory neuro-oncology clinic setting using a structured psychiatric interview which followed current DSM-IV diagnostic criteria for MDD. This sample was interviewed and evaluated on a one-time basis. The patients were referred for evaluation on a consecutive basis. Multiple regression was used to model critical independent variables to predict MDD.Twenty-eight percent of the sample (N=89) were found to have major depressive disorder using DSM-IV criteria. Key predictors of MDD included frontal region of tumor location (p=0.001), combined sadness and lack of motivation symptoms (p=0.0001), and family psychiatric history (p=0.006). The multiple regression models account for 37% of variance in predicting MDD (R(2)=0.37).A substantially higher incidence of MDD was found in this sample of adult brain tumor patients compared with other adult, ambulatory cancer patients previously evaluated with DSM criteria. The incidence of MDD was about triple that found in other published studies using DSM criteria. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12112483     DOI: 10.1002/pon.562

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  50 in total

Review 1.  Psychosocial distress and its effects on the health-related quality of life of primary brain tumor patients.

Authors:  Dina Randazzo; Katherine B Peters
Journal:  CNS Oncol       Date:  2016-07-11

2.  Effect of massage therapy on stress levels and quality of life in brain tumor patients--observations from a pilot study.

Authors:  Stephen Thomas Keir
Journal:  Support Care Cancer       Date:  2010-11-03       Impact factor: 3.603

3.  Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species.

Authors:  Pierre Montay-Gruel; Munjal M Acharya; Kristoffer Petersson; Leila Alikhani; Chakradhar Yakkala; Barrett D Allen; Jonathan Ollivier; Benoit Petit; Patrik Gonçalves Jorge; Amber R Syage; Thuan A Nguyen; Al Anoud D Baddour; Celine Lu; Paramvir Singh; Raphael Moeckli; François Bochud; Jean-François Germond; Pascal Froidevaux; Claude Bailat; Jean Bourhis; Marie-Catherine Vozenin; Charles L Limoli
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-16       Impact factor: 11.205

4.  Barriers to managing sleep disturbance in people with malignant brain tumours and their caregivers: a qualitative analysis of healthcare professionals' perception.

Authors:  Megan S Jeon; Meera R Agar; Eng-Siew Koh; Anna K Nowak; Elizabeth J Hovey; Haryana M Dhillon
Journal:  Support Care Cancer       Date:  2021-01-02       Impact factor: 3.603

Review 5.  Neuro-oncology and palliative care: a challenging interface.

Authors:  Esther Lin; Mark A Rosenthal; Brian H Le; Peter Eastman
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

Review 6.  Depression and glioblastoma, complicated concomitant diseases: a systemic review of published literature.

Authors:  Luke Mugge; Tarek R Mansour; Megan Crippen; Yasaman Alam; Jason Schroeder
Journal:  Neurosurg Rev       Date:  2018-08-09       Impact factor: 3.042

7.  Neurobehavioural changes in patients following brain tumour: patients and relatives perspective.

Authors:  N Gregg; A Arber; K Ashkan; L Brazil; R Bhangoo; R Beaney; R Gullan; V Hurwitz; A Costello; L Yágüez
Journal:  Support Care Cancer       Date:  2014-05-28       Impact factor: 3.603

Review 8.  Depression screening in patients with brain tumors: a review.

Authors:  Aiste Pranckeviciene; Adomas Bunevicius
Journal:  CNS Oncol       Date:  2015

9.  Prediction of neurocognitive outcome in adult brain tumor patients.

Authors:  Thomas A Kaleita; David K Wellisch; Timothy F Cloughesy; Judith M Ford; Donald Freeman; Thomas R Belin; Jeffrey Goldman
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

10.  Mood disturbance in glioma patients.

Authors:  A A Acquaye; E Vera-Bolanos; T S Armstrong; M R Gilbert; L Lin
Journal:  J Neurooncol       Date:  2013-05-16       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.